🕵️ Insight Molecular Diagnostics Inc. ($IMDX)
SEC insider & ownership activity, last 12 months · CIK 1642380 · every row links its SEC filing
Over the last 12 months insiders bought $5.7M with no open-market selling against it. Broadwood Partners, L.P. bought $5.7M (Feb–Apr). Neal C. Bradsher added 37.4% → 39.7%; Broadwood Partners, L.P. added 37.4% → 39.7%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $5.7M (14 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Broadwood Partners, L.P. | 14 | $5.7M | 0 | – | Apr 27, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Neal C. Bradsher | 39.7% | 13D | Apr 23, 2026 | filing ↗ | |
| Broadwood Partners, L.P. | 39.7% | 13D | Apr 23, 2026 | filing ↗ | |
| Broadwood Capital, Inc. | 39.7% | 13D | Apr 23, 2026 | filing ↗ | |
| Patrick W. Smith | 10.5% | 13G | Dec 27, 2024 | filing ↗ | |
| Patrick W Smith (trustee) | 10.5% | 13G | Dec 27, 2024 | filing ↗ | |
| AWM Investment Company, Inc. | 10.0% | 13G | May 9, 2025 | filing ↗ | |
| Bio-Rad Laboratories, Inc | 9.7% | 13G | Mar 4, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jun 11, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Other events (8.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Other events (8.01) | Feb 20, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 10, 2026 | filing ↗ |
| Other events (8.01) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 28, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 16, 2025 | filing ↗ |
| Earnings (2.02) | Aug 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2025 | filing ↗ |